{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:53:45Z","timestamp":1791312825185,"version":"4.3.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["BOF\/TOP 39705"],"award-info":[{"award-number":["BOF\/TOP 39705"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["IOF\/SBO 43782"],"award-info":[{"award-number":["IOF\/SBO 43782"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["IOF\/SBO 43782"],"award-info":[{"award-number":["IOF\/SBO 43782"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["BOF\/TOP 39705"],"award-info":[{"award-number":["BOF\/TOP 39705"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","award":["STK 46773"],"award-info":[{"award-number":["STK 46773"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-024-01790-z","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T16:16:46Z","timestamp":1733242606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genome-wide DNA methylation analysis reveals a unique methylation pattern for pleural mesothelioma compared to healthy pleura and other lung diseases"],"prefix":"10.1186","volume":"16","author":[{"given":"Janah","family":"Vandenhoeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"De Meulenaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen M. H.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Van Schil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"van Meerbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Van Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-6838","authenticated-orcid":false,"given":"Ken","family":"Op de Beeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"1790_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1055\/s-0039-1693406","volume":"40","author":"RY Kim","year":"2019","unstructured":"Kim RY, Sterman DH, Haas AR. Malignant mesothelioma: has anything changed? Semin Respir Crit Care Med. 2019;40:347\u201360.","journal-title":"Semin Respir Crit Care Med"},{"key":"1790_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1164\/rccm.200806-955ED","volume":"178","author":"JP van Meerbeeck","year":"2008","unstructured":"van Meerbeeck JP, Hillerdal G. Screening for mesothelioma. Am J Respir Crit Care Med. 2008;178:781\u20132.","journal-title":"Am J Respir Crit Care Med"},{"key":"1790_CR3","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/carcin\/bgn059","volume":"29","author":"BC Christensen","year":"2008","unstructured":"Christensen BC, et al. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis. 2008;29:1555\u20139.","journal-title":"Carcinogenesis"},{"key":"1790_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jtho.2023.01.095","volume":"18","author":"J Huang","year":"2023","unstructured":"Huang J, et al. Global incidence, risk factors, and temporal trends of mesothelioma: a population-based study. J Thorac Oncol. 2023;18:792\u2013802.","journal-title":"J Thorac Oncol"},{"key":"1790_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","volume":"397","author":"P Baas","year":"2021","unstructured":"Baas P, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet. 2021;397:375\u201386.","journal-title":"Lancet"},{"key":"1790_CR6","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/onc.2013.476","volume":"33","author":"M Cioce","year":"2014","unstructured":"Cioce M, et al. Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma. Oncogene. 2014;33:5319\u201331.","journal-title":"Oncogene"},{"issue":"2","key":"1790_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00001622-200303000-00002","volume":"15","author":"P Baas","year":"2003","unstructured":"Baas P. Predictive and prognostic factors in malignant pleural mesothelioma. Curr Opin Oncol. 2003;15(2):127\u201330.","journal-title":"Curr Opin Oncol"},{"key":"1790_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.annonc.2021.11.005","volume":"33","author":"S Popat","year":"2022","unstructured":"Popat S, et al. Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2022;33:129\u201342.","journal-title":"Ann Oncol"},{"key":"1790_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/MCP.0b013e32812144bb","volume":"13","author":"A Scherpereel","year":"2007","unstructured":"Scherpereel A, Lee YG. Biomarkers for mesothelioma. Curr Opin Pulm Med. 2007;13:339\u201343.","journal-title":"Curr Opin Pulm Med"},{"key":"1790_CR10","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.21037\/tlcr.2019.11.29","volume":"9","author":"DB Chapel","year":"2020","unstructured":"Chapel DB, Schulte JJ, Husain AN, Krausz T. Application of immunohistochemistry in diagnosis and management of malignant mesothelioma. Transl Lung Cancer Res. 2020;9:S3.","journal-title":"Transl Lung Cancer Res"},{"key":"1790_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.lungcan.2022.06.008","volume":"170","author":"P Jurmeister","year":"2022","unstructured":"Jurmeister P, et al. DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas. Lung Cancer. 2022;170:105\u201313.","journal-title":"Lung Cancer"},{"issue":"6","key":"1790_CR12","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/ijms19061603","volume":"19","author":"K Oehl","year":"2018","unstructured":"Oehl K, Vrugt B, Opitz I, Meerang M. Heterogeneity in malignant pleural mesothelioma. Int J Mol Sci. 2018;19(6):1603.","journal-title":"Int J Mol Sci"},{"key":"1790_CR13","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1038\/s41416-022-01979-0","volume":"127","author":"S Hiltbrunner","year":"2022","unstructured":"Hiltbrunner S, et al. Genomic landscape of pleural and peritoneal mesothelioma tumours. Br J Cancer. 2022;127:1997\u20132005.","journal-title":"Br J Cancer"},{"key":"1790_CR14","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1158\/2159-8290.CD-18-0804","volume":"8","author":"J Hmeljak","year":"2018","unstructured":"Hmeljak J, et al. Integrative molecular characterization of malignant pleural mesothelioma. Cancer Discov. 2018;8:1549\u201365.","journal-title":"Cancer Discov"},{"key":"1790_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","volume":"69","author":"BC Christensen","year":"2009","unstructured":"Christensen BC, et al. Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res. 2009;69:227\u201334.","journal-title":"Cancer Res"},{"key":"1790_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.lungcan.2004.08.003","volume":"47","author":"JA Tsou","year":"2005","unstructured":"Tsou JA, et al. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. Lung Cancer. 2005;47:193\u2013204.","journal-title":"Lung Cancer"},{"key":"1790_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13176","author":"J Ibrahim","year":"2022","unstructured":"Ibrahim J, Op de Beeck K, Fransen E, Peeters M, Van Camp G. Genome-wide DNA methylation profiling and identification of potential pan-cancer and tumor-specific biomarkers. Mol Oncol. 2022. https:\/\/doi.org\/10.1002\/1878-0261.13176.","journal-title":"Mol Oncol"},{"key":"1790_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/J.JTHO.2021.05.015","author":"J Vandenhoeck","year":"2021","unstructured":"Vandenhoeck J, et al. DNA methylation as a diagnostic biomarker for malignant mesothelioma: a systematic review and meta-analysis. J Thorac Oncol. 2021. https:\/\/doi.org\/10.1016\/J.JTHO.2021.05.015.","journal-title":"J Thorac Oncol"},{"key":"1790_CR19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jmoldx.2021.04.002","volume":"23","author":"L Bertero","year":"2021","unstructured":"Bertero L, et al. DNA methylation profiling discriminates between malignant pleural mesothelioma and neoplastic or reactive histologic mimics. J Mol Diagn. 2021;23:834\u201346.","journal-title":"J Mol Diagn"},{"key":"1790_CR20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","volume":"30","author":"TJ Morris","year":"2014","unstructured":"Morris TJ, et al. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics. 2014;30:428\u201330.","journal-title":"Bioinformatics"},{"issue":"4","key":"1790_CR21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/bioinformatics\/btw691","volume":"33","author":"JP Fortin","year":"2017","unstructured":"Fortin JP, Triche TJ Jr, Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017;33(4):558\u201360.","journal-title":"Bioinformatics"},{"key":"1790_CR22","doi-asserted-by":"publisher","DOI":"10.2202\/1557-4679.1103","author":"DH Glueck","year":"2008","unstructured":"Glueck DH, Mandel J, Karimpour-Fard A, Hunter L, Muller KE. Exact calculations of average power for the Benjamini-Hochberg procedure. Int J Biostat. 2008. https:\/\/doi.org\/10.2202\/1557-4679.1103.","journal-title":"Int J Biostat"},{"key":"1790_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giac128","author":"AD Genova","year":"2022","unstructured":"Genova AD, et al. A molecular phenotypic map of malignant pleural mesothelioma. Gigascience. 2022. https:\/\/doi.org\/10.1093\/gigascience\/giac128.","journal-title":"Gigascience"},{"key":"1790_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11276-9","author":"N Alcala","year":"2019","unstructured":"Alcala N, et al. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Nat Commun. 2019. https:\/\/doi.org\/10.1038\/s41467-019-11276-9.","journal-title":"Nat Commun"},{"key":"1790_CR25","unstructured":"Institute WS COSMIC cataloque of somatic mutations in cancer. (2023). Available at: https:\/\/cancer.sanger.ac.uk\/cosmic. (Accessed: 25th January 2024)"},{"key":"1790_CR26","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1073\/pnas.0712399105","volume":"105","author":"DJ Sugarbaker","year":"2008","unstructured":"Sugarbaker DJ, et al. Transcriptome sequencing of malignant pleural mesothelioma tumors. Proc Natl Acad Sci U S A. 2008;105:3521\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1790_CR27","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/cancers14051221","volume":"14","author":"B Vezzani","year":"2022","unstructured":"Vezzani B, et al. Epigenetic regulation: a link between inflammation and carcinogenesis. Cancers (Basel). 2022;14(5):1221.","journal-title":"Cancers (Basel)."},{"key":"1790_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-319-43624-1_7","volume":"945","author":"R Lakshminarasimhan","year":"2016","unstructured":"Lakshminarasimhan R, Liang G. The role of DNA methylation in cancer. Adv Exp Med Biol. 2016;945:151\u201372.","journal-title":"Adv Exp Med Biol"},{"issue":"22","key":"1790_CR29","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1200\/JCO.2004.07.151","volume":"22","author":"PM Das","year":"2004","unstructured":"Das PM, Singal R. DNA methylation and cancer. J Clinic Oncol. 2004;22(22):4632\u201342. https:\/\/doi.org\/10.1200\/JCO.2004.07.151.","journal-title":"J Clinic Oncol"},{"issue":"3","key":"1790_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"36","author":"PA Jones","year":"2002","unstructured":"Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;36(3):415\u201328.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"1790_CR31","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1200\/JCO.1999.17.5.1618","volume":"17","author":"CM Croce","year":"1999","unstructured":"Croce CM, Sozzi G, Huebner K. Role of FHIT in human cancer. J Clinic Oncol. 1999;17(5):1618\u20131618. https:\/\/doi.org\/10.1200\/JCO.1999.17.5.1618.","journal-title":"J Clinic Oncol"},{"key":"1790_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/00313020701716383","volume":"40","author":"E Tutar","year":"2008","unstructured":"Tutar E, Kiyici H. Role of fragile histidine triad protein expression in pathogenesis of malignant pleural mesothelioma. Pathology. 2008;40:42\u20135.","journal-title":"Pathology"},{"key":"1790_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00428-003-0902-3","volume":"444","author":"L Pylkk\u00e4nen","year":"2004","unstructured":"Pylkk\u00e4nen L, et al. Reduced Fhit protein expression in human malignant mesothelioma. Virchows Arch. 2004;444:43\u20138.","journal-title":"Virchows Arch"},{"key":"1790_CR34","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.3892\/ol.2017.6796","volume":"14","author":"G Bahari","year":"2017","unstructured":"Bahari G, Hashemi M, Naderi M, Sadeghi-Bojd S, Taheri M. FHIT promoter DNA methylation and expression analysis in childhood acute lymphoblastic leukemia. Oncol Lett. 2017;14:5034.","journal-title":"Oncol Lett"},{"key":"1790_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10585-022-10168-5","volume":"39","author":"B Wu","year":"2022","unstructured":"Wu B, et al. PLXDC2 enhances invadopodium formation to promote invasion and metastasis of gastric cancer cells via interacting with PTP1B. Clin Exp Metastasis. 2022;39:691\u2013710.","journal-title":"Clin Exp Metastasis"},{"key":"1790_CR36","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3389\/fonc.2019.01293","volume":"9","author":"M Tomasetti","year":"2019","unstructured":"Tomasetti M, Gaetani S, Monaco F, Neuzil J, Santarelli L. Epigenetic regulation of miRNA expression in malignant mesothelioma: mirnas as biomarkers of early diagnosis and therapy. Front Oncol. 2019;9:1293.","journal-title":"Front Oncol"},{"key":"1790_CR37","doi-asserted-by":"publisher","first-page":"17300","DOI":"10.18632\/oncotarget.24644","volume":"9","author":"L Nicol\u00e8","year":"2018","unstructured":"Nicol\u00e8 L, Cappellesso R, Sanavia T, Guzzardo V, Fassina A. MiR-21 over-expression and programmed cell death 4 down-regulation features malignant pleural mesothelioma. Oncotarget. 2018;9:17300.","journal-title":"Oncotarget"},{"key":"1790_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2012","unstructured":"Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacol. 2012;38:23\u201338.","journal-title":"Neuropsychopharmacol"},{"key":"1790_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-021-00272-1","volume":"9","author":"AE Jenike","year":"2021","unstructured":"Jenike AE, Halushka MK. miR-21: a non-specific biomarker of all maladies. Biomark Res. 2021;9:1\u20137.","journal-title":"Biomark Res"},{"key":"1790_CR40","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.molonc.2014.11.007","volume":"9","author":"MB Kirschner","year":"2015","unstructured":"Kirschner MB, et al. MiR-score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma. Mol Oncol. 2015;9:715\u201326.","journal-title":"Mol Oncol"},{"key":"1790_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe5877","author":"W Wang","year":"2021","unstructured":"Wang W, et al. RNF39 mediates K48-linked ubiquitination of DDX3X and inhibits RLR-dependent antiviral immunity. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abe5877.","journal-title":"Sci. Adv."},{"key":"1790_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.738709","author":"L Feng","year":"2021","unstructured":"Feng L, et al. Comprehensive analysis of E3 ubiquitin ligases reveals ring finger protein 223 as a novel oncogene activated by KLF4 in pancreatic cancer. Front Cell Dev Biol. 2021. https:\/\/doi.org\/10.3389\/fcell.2021.738709.","journal-title":"Front Cell Dev Biol"},{"key":"1790_CR43","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7968","volume":"2019","author":"J Liu","year":"2019","unstructured":"Liu J, et al. Identification of key genes and pathways associated with cholangiocarcinoma development based on weighted gene correlation network analysis. PeerJ. 2019;2019: e7968.","journal-title":"PeerJ"},{"key":"1790_CR44","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.3390\/cancers13246291","volume":"13","author":"MA Bauer","year":"2021","unstructured":"Bauer MA, et al. Genome-wide dna methylation signatures predict the early asymptomatic doxorubicin-induced cardiotoxicity in breast cancer. Cancers (Basel). 2021;13:6291.","journal-title":"Cancers (Basel)"},{"key":"1790_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-022-10466-x","volume":"23","author":"YD Li","year":"2023","unstructured":"Li YD, et al. Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy. BMC Cancer. 2023;23:1\u201314.","journal-title":"BMC Cancer"},{"issue":"11","key":"1790_CR46","first-page":"1","volume":"117","author":"Y Li","year":"2020","unstructured":"Li Y, et al. SPEN induces miR-4652\u20133p to target HIPK2 in nasopharyngeal carcinoma. Cell Death Dis. 2020;117(11):1\u201312.","journal-title":"Cell Death Dis"},{"key":"1790_CR47","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1158\/0008-5472.CAN-14-3475","volume":"75","author":"S L\u00e9gar\u00e9","year":"2015","unstructured":"L\u00e9gar\u00e9 S, et al. The estrogen receptor cofactor SPEN functions as a tumor suppressor and candidate biomarker of drug responsiveness in hormone-dependent breast cancers. Cancer Res. 2015;75:4351\u201363.","journal-title":"Cancer Res"},{"key":"1790_CR48","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1158\/0008-5472.CAN-21-2948","volume":"82","author":"Y Meng","year":"2022","unstructured":"Meng Y, et al. Genome-wide association analyses identify CATSPERE as a mediator of colorectal cancer susceptibility and progression. Cancer Res. 2022;82:986\u201397.","journal-title":"Cancer Res"},{"key":"1790_CR49","first-page":"219","volume":"4","author":"DJ Weisenberger","year":"2015","unstructured":"Weisenberger DJ, Liang G. Contributions of DNA methylation aberrancies in shaping the cancer epigenome. Transl Cancer Res. 2015;4:219\u201334.","journal-title":"Transl Cancer Res"},{"key":"1790_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-023-11764-8","volume":"24","author":"W Wang","year":"2024","unstructured":"Wang W, et al. SEPT9: From pan-cancer to lung squamous cell carcinoma. BMC Cancer. 2024;24:1\u201320.","journal-title":"BMC Cancer"},{"key":"1790_CR51","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.acc.2015.07.004","volume":"72","author":"L Song","year":"2015","unstructured":"Song L, Li Y. SEPT9: a specific circulating biomarker for colorectal cancer. Adv Clin Chem. 2015;72:171\u2013204.","journal-title":"Adv Clin Chem"},{"key":"1790_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-022-00385-x","volume":"27","author":"R Li","year":"2022","unstructured":"Li R, Wang X, Zhu C, Wang K. lncRNA PVT1: a novel oncogene in multiple cancers. Cell Mol Biol Lett. 2022;27:1\u201344.","journal-title":"Cell Mol Biol Lett"},{"key":"1790_CR53","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/epi.09.33","volume":"1","author":"M Ehrlich","year":"2009","unstructured":"Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics. 2009;1:239.","journal-title":"Epigenomics"},{"key":"1790_CR54","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2022.5351","author":"Y Endo","year":"2022","unstructured":"Endo Y, et al. Genome-wide DNA hypomethylation drives a more invasive pancreatic cancer phenotype and has predictive occult distant metastasis and prognosis potential. Int J Oncol. 2022. https:\/\/doi.org\/10.3892\/ijo.2022.5351.","journal-title":"Int J Oncol"},{"key":"1790_CR55","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3389\/fonc.2020.01152","volume":"10","author":"S Romero-Garcia","year":"2020","unstructured":"Romero-Garcia S, Prado-Garcia H, Carlos-Reyes A. Role of DNA methylation in the resistance to therapy in solid tumors. Front Oncol. 2020;10:1152.","journal-title":"Front Oncol"},{"key":"1790_CR56","doi-asserted-by":"publisher","first-page":"e106290","DOI":"10.1371\/journal.pone.0106290","volume":"9","author":"J Li","year":"2014","unstructured":"Li J, et al. The prognostic value of global DNA hypomethylation in cancer: a meta-analysis. PLoS One. 2014;9:e106290.","journal-title":"PLoS One"},{"key":"1790_CR57","doi-asserted-by":"publisher","first-page":"924","DOI":"10.21037\/tlcr.2020.03.38","volume":"9","author":"L Brcic","year":"2020","unstructured":"Brcic L, Kern I. Clinical significance of histologic subtyping of malignant pleural mesothelioma. Transl Lung Cancer Res. 2020;9:924.","journal-title":"Transl Lung Cancer Res"},{"key":"1790_CR58","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555:469\u201374.","journal-title":"Nature"},{"key":"1790_CR59","doi-asserted-by":"publisher","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-09-1595","volume":"69","author":"Y Goto","year":"2009","unstructured":"Goto Y, et al. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma. Cancer Res. 2009;69:9073\u201382.","journal-title":"Cancer Res"},{"key":"1790_CR60","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/ijc.31939","volume":"144","author":"S Dietz","year":"2019","unstructured":"Dietz S, et al. Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas. Int J Cancer. 2019;144:1061\u201372.","journal-title":"Int J Cancer"},{"key":"1790_CR61","doi-asserted-by":"publisher","first-page":"8513","DOI":"10.1126\/scitranslmed.aaw8513","volume":"11","author":"P Jurmeister","year":"2019","unstructured":"Jurmeister P, et al. Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases. Sci Transl Med. 2019;11:8513.","journal-title":"Sci Transl Med"},{"key":"1790_CR62","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s12276-020-00493-8","volume":"52","author":"JW Cho","year":"2020","unstructured":"Cho JW, et al. Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer. Exp Mol Med. 2020;52:1550.","journal-title":"Exp Mol Med"},{"key":"1790_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s12276-021-00718-4","volume":"54","author":"JW Cho","year":"2022","unstructured":"Cho JW, et al. The importance of enhancer methylation for epigenetic regulation of tumorigenesis in squamous lung cancer. Exp Mol Med. 2022;54:12.","journal-title":"Exp Mol Med"},{"key":"1790_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00931-w","author":"C Meiller","year":"2021","unstructured":"Meiller C, et al. Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma. Genome Med. 2021. https:\/\/doi.org\/10.1186\/s13073-021-00931-w.","journal-title":"Genome Med."},{"key":"1790_CR65","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1158\/1078-0432.CCR-22-0391","volume":"28","author":"K Guidry","year":"2022","unstructured":"Guidry K, et al. DNA methylation profiling identifies subgroups of lung adenocarcinoma with distinct immune cell composition, DNA methylation age, and clinical outcome. Clin Cancer Res. 2022;28:3824\u201335.","journal-title":"Clin Cancer Res"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-024-01790-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-024-01790-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-024-01790-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T18:02:23Z","timestamp":1733248943000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-024-01790-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1790"],"URL":"https:\/\/doi.org\/10.1186\/s13148-024-01790-z","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki. Fresh frozen PM tissue samples used in this study were previously collected in the Biobank of the Antwerp University Hospital and retrospectively used in this study which was approved by the UZA ethical committee (Reference number 16\/23\/248). According to Article 20 of the Belgian Law on the procurement and use of human corporal material intended for human application or scientific research of 19 December 2008, patients provide consent for the use of their bodily material in research when consenting to an invasive procedure. As such, no additional consent was needed for the use of these retrospective samples. For prospectively collected healthy pleural tissue samples, written informed consent was given by each subject. The study protocol was approved by the UZA ethical committee (EDGE number 002046) before experimental analyses were performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}